A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease

BACKGROUND: Patients with peripheral arterial disease (PAD) are limited by intermittent claudication in the distance they can walk. Allopurinol has been shown in coronary arterial disease to prolong exercise before angina occurs, likely by prevention of oxygen wastage in tissues and reduction of har...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Alan J., Struthers, Allan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pulsus Group 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742517/
https://www.ncbi.nlm.nih.gov/pubmed/26277090
http://dx.doi.org/10.1016/j.cjca.2015.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742517/
https://www.ncbi.nlm.nih.gov/pubmed/26277090
http://dx.doi.org/10.1016/j.cjca.2015.05.010

Ejemplares similares